S.A. Hoyng

Medicine & Life Sciences

1. Genetic Therapy 100%
2. Peripheral Nerves 71%
3. Glial Cell Line-Derived Neurotrophic Factor 57%
4. Viral Genes 53%
5. Trans-Activators 52%
6. Schwann Cells 51%
7. Regeneration 47%
8. Axons 46%
9. Neuroglia 38%
10. Switch Genes 32%
11. Osteochondrodysplasias 31%
12. Ciliary Neurotrophic Factor 30%
13. Foramen Magnum 30%
14. N-glycylalanine 28%
15. Nerve Growth Factors 26%
16. Paresthesia 24%
17. Autografts 23%
18. Nerve Growth Factor 23%
19. Brain-Derived Neurotrophic Factor 22%
20. Tetracycline 22%
21. Proteins 20%
22. EBV-encoded nuclear antigen 1 19%
23. Vascular Endothelial Growth Factor A 18%
24. Epstein-Barr Virus Nuclear Antigens 18%
25. Spinal Cord 17%
26. Nervous System 17%
27. Genes 17%
28. Gene Expression 15%
29. Capsid 14%
30. In Vitro Techniques 13%
31. Retinaldehyde 13%
32. caN protocol 13%
33. Phase II Clinical Trials 13%
34. Clinical Trials, Phase I 13%
35. Cell Line 12%
36. Neurobiology 12%
37. Retinal Diseases 12%
38. Craniotomy 11%
39. Peripheral Nervous System 11%
40. Neurosciences 11%
41. Eye Diseases 11%
42. Alanine 10%
43. Glycine 10%
44. Decompression 10%
45. Skull 10%
46. Brain Diseases 10%
47. Transfer Factor 10%
48. Immune System 9%